Loading market dashboard

Financials in GBp. Standardized financial statements.
A compact view of how International Biotechnology Trust plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £18.69M | £42.34M | £8.49M | £22.14M | £29.12M | £54.65M | -£16.58M | £21.10M | £46.35M | -£6.06M |
| Revenue Growth? | -55.9% | +398.4% | -61.6% | -24.0% | -46.7% | +429.5% | -178.6% | -54.5% | +864.5% | 0.0% |
| Cost of Revenue? | £4.30M | £2.20M | £2.32M | £2.48M | £2.75M | £2.12M | £2.58M | £1.70M | £2.48M | £2.47M |
| Gross Profit? | £14.38M | £40.14M | £6.17M | -£13.58M | £32.03M | £52.52M | -£19.16M | £19.41M | £43.87M | -£8.53M |
| Gross Margin? | +77.0% | +94.8% | +72.6% | -61.3% | +110.0% | +96.1% | +115.6% | +92.0% | +94.7% | +140.7% |
| Operating Expenses? | £14.40M | £1.13M | £3.88M | £1.22M | £1.07M | £1.05M | £862,000 | £1.10M | £1.03M | £1.05M |
| Operating Income? | -£21,000 | £39.55M | £6.59M | -£17.28M | £28.20M | £53.59M | -£17.44M | £20.23M | £45.52M | -£6.90M |
| EBITDA? | -£21,000 | £39.55M | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
| Income Before Tax | -£1.14M | £39.01M | £6.93M | -£22.32M | £28.05M | £53.59M | -£17.44M | £20.01M | £45.32M | -£7.11M |
| Income Tax Expense | £28,000 | £135,000 | £122,000 | £151,000 | £162,000 | £170,000 | £96,000 | £48,000 | £69,000 | £105,000 |
| Net Income? | -£1.17M | £38.88M | £6.81M | -£22.47M | £27.89M | £53.42M | -£17.54M | £19.96M | £45.25M | -£7.21M |
| EPS? | £-0.03 | £1.02 | £0.17 | £-0.55 | £0.69 | £1.39 | £-0.46 | £0.53 | £1.21 | £-0.19 |
| Diluted EPS? | £-0.03 | £1.02 | £0.17 | £-0.55 | £0.69 | £1.39 | £-0.46 | £0.53 | £1.21 | £-0.19 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality